A detailed history of Pensionmark Financial Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Pensionmark Financial Group, LLC holds 11,083 shares of AMGN stock, worth $3.11 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
11,083
Previous 288,608 96.16%
Holding current value
$3.11 Million
Previous $93 Million 96.16%
% of portfolio
0.12%
Previous 0.51%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024

SELL
$309.38 - $337.38 $85.9 Million - $93.6 Million
-277,525 Reduced 96.16%
11,083 $3.57 Million
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $87 Million - $94.9 Million
281,141 Added 3765.11%
288,608 $93 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $1.5 Million - $1.82 Million
5,691 Added 320.44%
7,467 $2.33 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $412,984 - $498,524
-1,536 Reduced 46.38%
1,776 $504,000
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $369,230 - $416,536
1,444 Added 77.3%
3,312 $953,000
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $80,025 - $99,354
366 Added 24.37%
1,868 $502,000
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $15,579 - $18,988
-69 Reduced 4.39%
1,502 $363,000
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $90,237 - $114,657
-394 Reduced 20.05%
1,571 $412,000
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $50,503 - $56,958
-225 Reduced 10.27%
1,965 $443,000
Q2 2022

Aug 09, 2022

SELL
$230.71 - $256.74 $5,537 - $6,161
-24 Reduced 1.08%
2,190 $541,000
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $16,664 - $18,435
-76 Reduced 3.32%
2,214 $535,000
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $49,918 - $57,127
-251 Reduced 9.88%
2,290 $524,000
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $61,558 - $72,123
290 Added 12.88%
2,541 $540,000
Q2 2021

Aug 12, 2021

BUY
$233.58 - $259.14 $46,482 - $51,568
199 Added 9.7%
2,251 $549,000
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $34,617 - $40,341
156 Added 8.23%
2,052 $517,000
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $26,831 - $31,951
-124 Reduced 6.14%
1,896 $453,000
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $32,381 - $36,011
138 Added 7.33%
2,020 $513,000
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $372,278 - $456,836
1,882 New
1,882 $455,000
Q3 2019

Nov 12, 2019

SELL
$174.11 - $208.62 $1.85 Million - $2.22 Million
-10,623 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$166.7 - $195.41 $1.77 Million - $2.08 Million
10,623 New
10,623 $127,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pensionmark Financial Group, LLC Portfolio

Follow Pensionmark Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pensionmark Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pensionmark Financial Group, LLC with notifications on news.